Dr. David S Siegel
Claim this profileHackensack University Medical Center
Studies Multiple Myeloma
Studies Plasma Cell Neoplasms
9 reported clinical trials
24 drugs studied
Area of expertise
1Multiple Myeloma
t(4;14) positive
GOF mutation in MMSET positive
2Plasma Cell Neoplasms
t(4;14) positive
GOF mutation in MMSET positive
Affiliated Hospitals
Clinical Trials David S Siegel is currently running
MMSET Inhibitor
for Multiple Myeloma
This trial tests a new pill that blocks an enzyme to help treat adults with a hard-to-treat type of blood cancer. The goal is to see if it is safe and effective.
Recruiting1 award Phase 113 criteria
CC-92480 + Other Drugs
for Multiple Myeloma
The purpose of this study is to assess the safety, tolerability and preliminary effectiveness of CC-92480 (BMS-986348) in novel therapeutic combinations for the treatment of Relapsed or Refractory Multiple Myeloma (RRMM).
Recruiting2 awards Phase 1 & 25 criteria
More about David S Siegel
Clinical Trial Related6 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments David S Siegel has experience with
- Dexamethasone
- Bortezomib
- CC-220
- KTX-1001
- BB2121
- Pomalidomide
Breakdown of trials David S Siegel has run
Multiple Myeloma
Plasma Cell Neoplasms
Sarcoma
Squamous Cell Carcinoma
Chronic Lymphocytic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David S Siegel specialize in?
David S Siegel focuses on Multiple Myeloma and Plasma Cell Neoplasms. In particular, much of their work with Multiple Myeloma has involved t(4;14) positive patients, or patients who are GOF mutation in MMSET positive.
Is David S Siegel currently recruiting for clinical trials?
Yes, David S Siegel is currently recruiting for 3 clinical trials in Hackensack New Jersey. If you're interested in participating, you should apply.
Are there any treatments that David S Siegel has studied deeply?
Yes, David S Siegel has studied treatments such as Dexamethasone, Bortezomib, CC-220.
What is the best way to schedule an appointment with David S Siegel?
Apply for one of the trials that David S Siegel is conducting.
What is the office address of David S Siegel?
The office of David S Siegel is located at: Hackensack University Medical Center, Hackensack, New Jersey 07601 United States. This is the address for their practice at the Hackensack University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.